Literature DB >> 10436087

The hierarchy of mutations influencing the folding of antibody domains in Escherichia coli.

J G Wall1, A Plückthun.   

Abstract

In a systematic study of the periplasmic folding of antibody fragments in Escherichia coli, we have analysed the expression of an aggregation-prone and previously non-functional anti-phosphorylcholine antibody, T15, as a model system and converted it to a functional molecule. Introduction of heavy chain framework mutations previously found to improve the folding of a related antibody led to improved folding of T15 fragments and improved physiology of the host E.coli cells. Manipulation of the complementarity determining regions (CDR) of the framework-mutated forms of T15 further improved folding and bacterial host physiology, but no improvement was seen in the wild type, suggesting the existence of a hierarchy in sequence positions leading to aggregation. Rational mutagenesis of the T15 light chain led to the production of functional T15 fragments for the first time, with increased levels of functional protein produced from V(H) manipulated constructs. We propose that a hierarchical analysis of the primary amino acid sequence, as we have described, provides guidelines on how correctly folding, functional antibodies might be achieved and will allow further delineation of the decisive structural factors and pathways favouring protein aggregation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10436087     DOI: 10.1093/protein/12.7.605

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  4 in total

Review 1.  The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment.

Authors:  W W Cheng; T M Allen
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

2.  Cloning, expression, purification, and characterization of LC-1 ScFv with GFP tag.

Authors:  Min Lu; Xing-guo Gong; Hong Yu; Jian-yong Li
Journal:  J Zhejiang Univ Sci B       Date:  2005-08       Impact factor: 3.066

3.  Use of folding modulators to improve heterologous protein production in Escherichia coli.

Authors:  Olga Kolaj; Stefania Spada; Sylvain Robin; J Gerard Wall
Journal:  Microb Cell Fact       Date:  2009-01-27       Impact factor: 5.328

4.  Optimizing antibody expression by using the naturally occurring framework diversity in a live bacterial antibody display system.

Authors:  T Noelle Lombana; Michael Dillon; Jack Bevers; Christoph Spiess
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.